Routine testing by MDARD is positive for Listeria monocytogenes in Romaine

The Michigan Department of Agriculture and Rural Development (MDARD) is advising consumers not to eat Fresh Express Sweet Hearts Romaine Lettuce Sweet Butter Lettuce due to food safety concerns.

A sample of product collected as part of routine sampling in December and analyzed by MDARD has tested positive for Listeria monocytogenes. No cases of illness have been associated with this product in Michigan at this time

The product is packaged in a 9 oz. clear plastic bag with a green and red label with white lettering and has a use-by date and lot code of “DEC 08 Z324B05A 16:04 07; Product of the USA” located on the upper right corner of the front of the bag.

Any consumers who purchased the product are advised to not consume and dispose of it immediately.  If you think you or a family member may have become ill from consuming any of this product, seek immediate medical attention.

About Listeria infections

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still cause serious and sometimes life-threatening infections. Anyone who has eaten any recalled product and developed symptoms of Listeria infection should seek medical treatment and tell their doctors about the possible Listeria exposure.

Also, anyone who has eaten any of the recalled products should monitor themselves for the food poisoning symptoms during the coming weeks because it can take up to 70 days after exposure to Listeria for symptoms of listeriosis to develop.

Symptoms of Listeria infection can include vomiting, nausea, persistent fever, muscle aches, severe headache, and neck stiffness. Specific laboratory tests are required to diagnose Listeria infections, which can mimic other illnesses.

Pregnant women, the elderly, young children, and people such as cancer patients who have weakened immune systems are particularly at risk of serious illnesses, life-threatening infections, and other complications.  Although infected pregnant women may experience only mild, flu-like symptoms, their infections can lead to premature delivery, infection of the newborn, or even stillbirth.

(To sign up for a free subscription to Food Safety News, click here.)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
CIOs' 5-year plans for precision medicine and emerging technologies thumbnail

CIOs’ 5-year plans for precision medicine and emerging technologies

One of the next big shifts in patient care will be precision medicine will be "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment and lifestyle for each person," as the Precision Medicine Initiative describes it. For physicians and researchers this means predicting more accurately which treatment and prevention…
Read More
FDA Okays 6-Month Implanted Eversense CGM for Diabetes thumbnail

FDA Okays 6-Month Implanted Eversense CGM for Diabetes

The US Food and Drug Administration has approved a new second-generation version of the implanted continuous glucose monitoring (CGM) system Eversense (Senseonics) that lasts for 6 months. The Eversense E3 CGM system doubles the wear time from 3 months with the previous Eversense device approved in the United States in 2018. As before, the new…
Read More
Universidades no consiguen terapeutas para el creciente número de estudiantes en crisis thumbnail

Universidades no consiguen terapeutas para el creciente número de estudiantes en crisis

Al principio de su primer trimestre en la Universidad de California-Davis, Ryan Manríquez se dio cuenta que necesitaba ayuda. Una suma de presiones —evitar covid-19, superar una ruptura afectiva, lidiar con una discapacidad, tratar de mantenerse al día con un exigente calendario de clases— lo golpeó duro. “Sentí el impacto de inmediato”, dijo Manríquez, de…
Read More
Trial assesses antibody therapy for chronic active antibody-mediated kidney transplant rejection thumbnail

Trial assesses antibody therapy for chronic active antibody-mediated kidney transplant rejection

Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!Press and hold the buttonIf you believe this is an error, please contact our support team.2a02:4780:11:1216:0:30ec:e162:1 : 138ae4ad-dc50-4747-bd8d-a8b6c35b
Read More
Index Of News
Total
0
Share